MBOT Stock Overview
A pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Microbot Medical Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.99 |
| 52 Week High | US$2.35 |
| 52 Week Low | US$0.82 |
| Beta | 1.63 |
| 11 Month Change | 1.35% |
| 3 Month Change | 4.52% |
| 1 Year Change | -24.43% |
| 33 Year Change | -80.70% |
| 5 Year Change | -79.67% |
| Change since IPO | -99.35% |
Recent News & Updates
Recent updates
Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?
Dec 30
Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?
Sep 01Here's Why We're A Bit Worried About Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation
Dec 28Microbot Medical acquires Nitiloop, terms undisclosed
Oct 07Here's Why We're Watching Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation
Sep 13Microbot Medical confirms GLP trial on track to begin later this month
Sep 02Will Microbot Medical (NASDAQ:MBOT) Spend Its Cash Wisely?
Apr 23Microbot Medical's Stryker Collaboration Makes This An Intriguing High Flier
Jan 06Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth
Dec 24We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth
Aug 27Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth
May 12We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth
Jan 27Microbot Medical's study of surgical robotic system meets endpoints
Jan 14Shareholder Returns
| MBOT | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 7.1% | 1.2% | 2.0% |
| 1Y | -24.4% | 22.6% | 32.4% |
Return vs Industry: MBOT underperformed the US Medical Equipment industry which returned 21.9% over the past year.
Return vs Market: MBOT underperformed the US Market which returned 32.6% over the past year.
Price Volatility
| MBOT volatility | |
|---|---|
| MBOT Average Weekly Movement | 6.7% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.9% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MBOT has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: MBOT's weekly volatility has decreased from 13% to 7% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 22 | Harel Gadot | microbotmedical.com |
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter.
Microbot Medical Inc. Fundamentals Summary
| MBOT fundamental statistics | |
|---|---|
| Market cap | US$16.76m |
| Earnings (TTM) | -US$11.20m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-1.5x
P/E RatioIs MBOT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MBOT income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$11.21m |
| Earnings | -US$11.20m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.66 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did MBOT perform over the long term?
See historical performance and comparison